AnaptysBio (ANAB) Stock Price, Quote, News & History | Benzinga

AnaptysBio (ANAB) Stock Price, Quote, News & History

ANABNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$50.54

3.136.60%

At close: Feb 2, 4:00 PM EST

$51.20

0.661.31%

After Hours: 5:35 PM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$47.05

Close

$50.54

Volume / Avg.

546.21K / 550.02K

Day Range

$47.05 - $50.98

52 Wk Range

12.21 - 52.47

Market Cap

$1.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

67

Short Interest

34.58%

Days to Cover

12.15

Recent AnaptysBio Inc News

AnaptysBio Pushes Back Against Lawsuit Over Cancer Drug Jemperli Royalties

AnaptysBio asks a Delaware court to dismiss Tesaro's breach claim, citing anti-SLAPP law in a dispute over Jemperli royalties and licensing rights.

Vandana Singh

GSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli Royalties

GSK's Tesaro sues AnaptysBio over alleged Jemperli contract breaches, putting royalties, milestones, and future licensing rights into question.

Vandana Singh

Elastic, Veeva Systems, HIVE Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-144.97M

Investing Cash Flow (TTM)

125.14M

Financing Cash Flow (TTM)

-61.91M

Free Cash Flow (TTM)

-145.32M

Capital Expenditure (TTM)

-349.00K

Net Change in Cash (TTM)

-81.75M

Analyst Trends and Forecast

3

Oct 25

6

Nov 25

2

Dec 25

2

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.17B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

8.78

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-5.58%

Earnings Yield % (FWD)

-9.25%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.06

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$109.83M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$47.05

Close

$50.54

Volume / Avg.

546.21K / 550.02K

Day Range

$47.05 - $50.98

52 Wk Range

12.21 - 52.47

Market Cap

$1.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

67

Short Interest

34.58%

Days to Cover

12.15

About

Sector

Health Care

Industry

Biotechnology

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, inclu...

Show More

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy AnaptysBio (ANAB) stock?

A

You can purchase shares of AnaptysBio (NASDAQ:ANAB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AnaptysBio (ANAB) competitors?

A

Other companies in AnaptysBio’s space includes: Precigen Inc (NASDAQ:PGEN), MoonLake Immunotherapeutics (NASDAQ:MLTX), Immatics NV (NASDAQ:IMTX), Day One Biopharmaceuticals Inc (NASDAQ:DAWN) and CareDx Inc (NASDAQ:CDNA).

Q

What is the forecast, or price target, for AnaptysBio (ANAB) stock?

A

AnaptysBio has a consensus price target of $59.93.

Q

What is the current price for AnaptysBio (ANAB)?

A

The stock price for AnaptysBio (NASDAQ: ANAB) is $51.2 last updated February 2, 2026 at 5:35 PM EST.

Q

Does AnaptysBio (ANAB) pay a dividend?

A

There are no upcoming dividends for AnaptysBio.

Q

When is AnaptysBio (NASDAQ:ANAB) reporting earnings?

A

AnaptysBio does not have any upcoming earnings scheduled.

Q

Is AnaptysBio (ANAB) going to split?

A

There is no upcoming split for AnaptysBio.

Q

What sector and industry does AnaptysBio (ANAB) operate in?

A

AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

MoonLake Immunotherapeutics

Day One Biopharmaceuticals Inc

Tango Therapeutics Inc